Company
Every investor coverage indicates participated in a round Charge CCCV raised.
Companies Charge CCCV acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Charge CCCV. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Manufacturing briefs roundup: Magnis and Charge CCCV report encouraging battery cell test results, Nova Eye starts United States testing of its glaucoma catheter, and Noxopharm collects a government research rebate.
ASX-listed battery maker Magnis entered a trading halt pending a planned capital raise, after a June raising and a Queensland government grant to its consortium for a Townsville gigafactory feasibility study; its CEO has departed.
Magnis Energy reports partner C4V tested an EV battery cell charging to 85% in six minutes; production could occur at Magnis's planned Townsville gigafactory, which received $3.1 million in Queensland government grants.